Matisse Capital Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SDHY
PGIM Short Duration High Yield Opportunities Fund
SDHY
|
+$1.49M |
| 2 |
JOF
Japan Smaller Capitalization Fund
JOF
|
+$1.26M |
| 3 |
PFD
Flaherty & Crumrine Preferred and Income Fund
PFD
|
+$1.22M |
| 4 |
BlackRock Municipal 2030 Target Term Trust
BTT
|
+$1.02M |
| 5 |
MXF
Mexico Fund
MXF
|
+$808K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
+$7.54M |
| 2 |
FSCO
FS Credit Opportunities Corp
FSCO
|
+$1.95M |
| 3 |
NML
Neuberger Energy Infrastructure and Income Fund Inc
NML
|
+$1.64M |
| 4 |
Invesco Municipal Trust
VKQ
|
+$944K |
| 5 |
NDP
TORTOISE ENERGY INDEPENDENCE FUND, INC.
NDP
|
+$893K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.46% |
| 2 | Financials | 5.23% |
| 3 | Healthcare | 4.75% |
| 4 | Industrials | 3.54% |
| 5 | Consumer Discretionary | 3.46% |
Similar funds
Matisse Capital's Q2 2024 Portfolio in Review
As of Q2 2024, Matisse Capital held 201 positions worth $202M, down 2.8% from $208M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Matisse Capital withdrew a net $8.32M in Q2 2024, closing 20 positions and reducing 22 holdings. Its most notable exit was Shockwave Medical, Inc. Common Stock, an estimated $7.54M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Matisse Capital opened a new position in PGIM Short Duration High Yield Opportunities Fund worth $1.5M.
- Matisse Capital's largest Q2 2024 buy was PGIM Short Duration High Yield Opportunities Fund: 98,000 shares worth $1.5M.
- Matisse Capital added most to Japan Smaller Capitalization Fund in Q2 2024, an estimated $1.26M increase.
- Matisse Capital's biggest Q2 2024 reduction was BlackRock Science and Technology Term Trust, cutting an estimated $780K.
- Matisse Capital fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $7.54M.
- Matisse Capital's ten largest holdings make up 24% of its $202M portfolio in Q2 2024.
- Matisse Capital opened 11 new positions and closed 20 in Q2 2024.
- Matisse Capital's portfolio value fell 2.8% quarter-over-quarter to $202M.
Based on Matisse Capital's 13F filing for Q2 2024, filed 30 Jul 2024.